Publications

You can use the filters to show only results that match your interests

Filter publications
344 publications by Medicines and Healthcare products Regulatory Agency ×
Get updates to this list email feed

Copy and paste this URL in to your feed reader

  1. Drug Safety Update: monthly PDF newsletter

    • MHRA
    • Guidance
  2. Early access to medicines scheme applications: pending, refused, granted

    • MHRA
    • Official Statistics
  3. Good clinical practice inspection metrics

  4. Medicines and Healthcare Products Regulatory Agency Annual Report and Accounts 2016 to 2017

    • MHRA
    • Corporate report
  5. Proposal to make Arthriex 750mg and 1500mg film-coated tablets available from Pharmacies

    • MHRA
    • Open consultation
  6. Marketing authorisations granted in June 2017

  7. Parallel import licenses granted in June 2017

  8. MHRA: business impact target

    • MHRA
    • Research and analysis
  9. Classification of Nasonex Allergy Control Nasal Spray

    • MHRA
    • Consultation outcome
  10. Suspended and revoked licences for manufacturers and wholesalers of medicines

  11. Register of brokers authorised to deal in human medicines

  12. Human and veterinary medicines: register of licensed wholesale distribution sites

  13. Early access to medicines scheme: expired scientific opinions

    • MHRA
    • Decision
  14. Human and veterinary medicines: register of licensed manufacturing sites 2017

  15. Medicines: terminated and cancelled manufacturing and wholesale dealer licences

  16. Medicines: new manufacturing and wholesale dealer licences

  17. Reclassification of Otrivine extra dual relief nasal spray solution (ARM 90)

    • MHRA
    • Consultation outcome
  18. Medicines: licensing time-based performance measures

    • MHRA
    • Official Statistics
  19. Clinical trials for medicines: authorisation assessment performance

    • MHRA
    • Transparency data
  20. Proposal to make Maloff Protect 250mg/100mg film-coated tablets available from Pharmacies

    • MHRA
    • Consultation outcome
  21. Notified bodies for medical devices

  22. Medical devices: UK notified bodies

  23. Early access to medicines scheme (EAMS) scientific opinion: Raxone to treat the decline of respiratory function in patients with Duchenne Muscular Dystrophy

  24. Better consultations, better evidence

    • MHRA
    • Research and analysis
  25. Advertising investigations: May 2017

  26. Post-implementation Review of the Human Medicines Regulations 2012 (MLX 391)

    • MHRA
    • Closed consultation
  27. Parallel import licences granted in May 2017

  28. Marketing authorisations granted in May 2017

  29. MHRA: requests under the Freedom of Information Act (FOIA)

    • MHRA
    • FOI release
  30. Advertising investigations: April 2017

  31. Marketing authorisations granted in April 2017

  32. Parallel import licences granted in April 2017

  33. Early access to medicines scheme (EAMS) scientific opinion: Glecaprevir/Pibrentasvir for the treatment of chronic hepatitis C (HCV) infection in adults

  34. Advertising investigations: March 2017

  35. Medicines and Healthcare products Regulatory Agency spending over £25,000: 2016 to 2017

    • MHRA
    • Transparency data
  36. Medical devices: software applications (apps)

  37. Medicines and Healthcare products Regulatory Agency Business Plan 2017 to 18

    • MHRA
    • Corporate report
  38. Good manufacturing practice inspection deficiencies

    • MHRA
    • Official Statistics
  39. MHRA: policy for handling conflicts of interest

    • MHRA
    • Corporate report
  40. Patient group directions (PGDs)

    • MHRA
    • Guidance